Hydralazine Hydrochloride
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
50228-184 -
Package NDC
50228-184-01 -
Package NDC
50228-184-10 -
Application number
ANDA205236 -
SPL ID
bcb83203-049e-1ddd-e053-2a95a90ae336 -
SPL set ID
500b7f76-5f4e-4e7d-85c3-18b9f66d7504 -
UNII
FD171B778Y -
RxCUI
905199 -
RxCUI
905222 -
RxCUI
905225 -
RxCUI
905395
What the source publishes
- Labeler
- ScieGen Pharmaceuticals, Inc.
- Active ingredients
- Hydralazine Hydrochloride
- Form
- TABLET
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Hydralazine Hydrochloride",
"splId": "bcb83203-049e-1ddd-e053-2a95a90ae336",
"labels": [
{
"setId": "500b7f76-5f4e-4e7d-85c3-18b9f66d7504",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=500b7f76-5f4e-4e7d-85c3-18b9f66d7504",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=500b7f76-5f4e-4e7d-85c3-18b9f66d7504"
}
],
"routes": [
"ORAL"
],
"labeler": "ScieGen Pharmaceuticals, Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "100 TABLET in 1 BOTTLE (50228-184-01)",
"package_ndc": "50228-184-01",
"identifierStatus": "well-formed",
"marketing_start_date": "20170526"
},
{
"sample": false,
"description": "1000 TABLET in 1 BOTTLE (50228-184-10)",
"package_ndc": "50228-184-10",
"identifierStatus": "well-formed",
"marketing_start_date": "20170526"
}
],
"productId": "50228-184_bcb83203-049e-1ddd-e053-2a95a90ae336",
"useDomain": "unknown",
"dosageForm": "TABLET",
"productNdc": "50228-184",
"deaSchedule": null,
"genericName": "Hydralazine Hydrochloride",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "HYDRALAZINE HYDROCHLORIDE",
"strength": "50 mg/1"
}
],
"applicationNumber": "ANDA205236",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20170526",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"upc": [
"0350228182010",
"0350228182102",
"0350228183017",
"0350228184014",
"0350228183109",
"0350228185103",
"0350228184106",
"0350228185011"
],
"unii": [
"FD171B778Y"
],
"rxcui": [
"905199",
"905222",
"905225",
"905395"
],
"spl_set_id": [
"500b7f76-5f4e-4e7d-85c3-18b9f66d7504"
],
"manufacturer_name": [
"ScieGen Pharmaceuticals, Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:50228-184_bcb83203-049e-1ddd-e053-2a95a90ae336"